Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,035.00    -3.50 (-0.34%)
Bid:
1,036.50
Ask:
1,037.00
Spread: 0.50 (0.048%)
Market Cap: £5.06b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

AGM trading update

25 Sep 2025 07:00

RNS Number : 7206A
Babcock International Group PLC
25 September 2025
 

25 September 2025

 

Babcock International Group PLC

AGM trading update

 

Continued positive momentum, full year expectations unchanged

 

Babcock International Group ("Babcock" or "the Group") provides a trading update for the first five months of the financial year ahead of its Annual General Meeting to be held at 11.00 am today.

Trading update to 31 August 2025

Trading in the first five months to 31 August 2025 has been encouraging, with the Group delivering organic revenue growth and underlying operating margin progress in line with the Board's expectations.

Strong growth in Nuclear, driven by civil nuclear projects and submarine support, and Aviation, as a result of the ramp-up of the French Mentor 2 contract, and ongoing growth in Marine was partly offset by lower revenue in Land, due to lower activity in the Rail business.

Overall, expectations for the full year remain unchanged and we continue to progress towards the Group's medium-term guidance, which we upgraded in June 2025 to average revenue growth of mid-single digit, underlying operating margin of at least 9% (previously at least 8%) and average operating cash conversion of at least 80%.

Developments in the period

The macro environment remains supportive, and we continue to make good strategic progress. In the period we welcomed the UK Government's Defence Industrial Strategy, which strongly aligns with our capabilities. Babcock's business momentum has continued through the period with sustained delivery and strategic progress to support future growth.

· Type 31 frigate programme - in April we were awarded a c£65 million Capability Insertion Programme contract on a sole source basis. In June, a major milestone was reached with float-off of the first ship, HMS Venturer. The second ship, HMS Active, is on track to float-off before the end of FY26.

 

· Submarine disposal - in June we secured a £114 million contract to support the first defueling of a decommissioned British nuclear submarine in over 20 years. We will work with the UK Defence Nuclear Enterprise and industry partners to prepare for the defuel of four decommissioned submarines at our Devonport facility from 2026.

 

· AUKUS - our joint venture with HII in Australia secured its first contract to enhance Australia's supply chain capabilities in preparation for delivery of the first three nuclear-powered submarines under the trilateral partnership.

 

· Australia - in September we signed a new AU$250 million, 8-year follow-on contract with the Australian Border Force (ABF) to enhance maritime security operations in the Torres Strait. The contract includes the delivery of two mission modified Airbus H145 helicopters to the ABF, plus air crews and ongoing maintenance over eight years.

 

· New AI intelligence product - in September we launched our first fully AI-powered communications intelligence product NomadTM which provides front-line military and security services with valuable intelligence in real-time.

 

· Significant industry partnerships - we announced collaborations with leading global industry players, including: a Memorandum of Understanding (MoU) with BAE Systems Bofurs to offer support for the Type 31's multi-purpose Bofurs guns; as UK build partner to Finnish armoured vehicle company Patria following the UK MOD's arrangement to join the multinational Common Armoured Vehicle System programme; as Hanwha Ocean's exclusive in-service support partner for the new Canadian Patrol Submarine Project; as HII's partner to deliver autonomous launch and recovery of Unmanned Underwater Vehicles via submarine torpedo tubes and; an MoU with radio communications equipment manufacturer KNL to offer next generation high frequency communications support to armed forces across the land, sea and air domains.

 

· Share buybacks - we have completed around 25% of the £200 million share buyback programme announced at our preliminary results on 25 June 2025. We expect the programme to conclude by the end of FY26.

 

· Refinancing of the Revolving Credit Facility (RCF) - in July, we successfully entered into a new RCF with ten banks which replaces the previous financing facility of £775 million. The new committed debt facility, which is valid for five years with 2 one-year extension options, will provide the Group with access to borrowings of up to an aggregate amount of £600 million, with an accordion option to increase this facility by up to £200 million at lenders discretion.

Additionally, during the period we held the first two of a series of investor events. These demonstrated potential for both our Marine Design and Build business and our Cavendish Nuclear business to double revenues by 2030. Links to the materials and event replays can be found on our website at www.babcockinternational.com/investors

HY26 half year results

The Group's HY26 half year results will be published on 20 November 2025.

 

 

ENDS

 

For further information:

Andrew Gollan, Director of Investor Relations +44 (0)7936 039004

Kate Hill, Group Head of Financial Communications +44 (0)20 7355 5312

Harry Cameron/Camilla Cunningham, Teneo +44 (0)20 7353 4200 

 

 

Certain statements in this announcement are forward-looking statements. Such statements may relate to Babcock's business, strategy and plans. Statements that are not historical facts, including statements about Babcock's or its management's beliefs and expectations, are forward-looking statements. Words such as 'believe', 'anticipate', 'estimates', 'expects', 'intends', 'aims', 'potential', 'will', 'would', 'could', 'considered', 'likely', and variations of these words and similar future or conditional expressions are intended to identify forward-looking statements but are not the exclusive means of doing so. By their nature, forward-looking statements involve a number of risks, uncertainties or assumptions, some known and some unknown, many of which are beyond Babcock's control that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties or assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this announcement regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. Nor are they indicative of future performance and Babcock's actual results of operations and financial condition and the development of the industry and markets in which Babcock operates may differ materially from those made in or suggested by the forward-looking statements. You should not place undue reliance on forward-looking statements because such statements relate to events and depend on circumstances that may or may not occur in the future. Except as required by law, Babcock is under no obligation to update (and will not) or keep current the forward-looking statements contained herein or to correct any inaccuracies which may become apparent in such forward-looking statements. 

Forward-looking statements reflect Babcock's judgement at the time of preparation of this announcement and are not intended to give any assurance as to future results.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMDZGZLGDLGKZZ
Date   Source Headline
6th Oct 20172:42 pmRNSAnna Stewart
20th Sep 20179:51 amRNSHolding(s) in Company
20th Sep 20177:00 amRNSTrading Update
8th Sep 201710:41 amRNSPublication of a Prospectus
17th Aug 201711:37 amRNSHolding(s) in Company
16th Aug 201711:54 amRNSDirector/PDMR Shareholding
13th Jul 20173:48 pmRNSResult of AGM
13th Jul 20177:00 amRNSAnnual General Meeting Trading Update
29th Jun 20177:00 amRNSContract Award
27th Jun 201712:32 pmRNSDirector/PDMR Shareholding
22nd Jun 201712:00 pmRNSDirector/PDMR Shareholding
20th Jun 201711:53 amRNSDirector/PDMR Shareholding
19th Jun 201710:53 amRNSDirector/PDMR Shareholding
15th Jun 20173:58 pmRNSDirector/PDMR Shareholding
13th Jun 20175:08 pmRNSNotice of AGM
7th Jun 20175:24 pmRNSHolding(s) in Company
7th Jun 20174:55 pmRNSDirector/PDMR Shareholding
7th Jun 20171:17 pmRNSDirector/PDMR Shareholding
1st Jun 201710:11 amRNSPublication of Final Terms
30th May 20175:23 pmRNSDirector/PDMR Shareholding
24th May 20173:43 pmRNSHolding(s) in Company
24th May 20177:00 amRNSFinal Results
19th May 20179:34 amRNSHolding(s) in Company
2nd May 20179:59 amRNSHolding(s) in Company
13th Apr 201710:09 amRNSHolding(s) in Company
13th Apr 20178:55 amRNSHolding(s) in Company
11th Apr 20179:26 amRNSHolding(s) in Company
3rd Apr 20177:00 amRNSPreferred bidder for Royal Navy support contract
29th Mar 20174:38 pmRNSHolding(s) in Company
27th Mar 20173:01 pmRNSDirector/PDMR Shareholding
27th Mar 20172:58 pmRNSDirector/PDMR Shareholding
27th Mar 201712:10 pmRNSDirector/PDMR Shareholding
27th Mar 20177:22 amRNSMagnox decommissioning contract
24th Mar 20179:54 amRNSHolding(s) in Company
14th Mar 20177:00 amRNSRealignment Presentation
28th Feb 20177:00 amRNSTrading Update
24th Feb 20171:00 pmRNSHolding(s) in Company
15th Feb 201712:11 pmRNSHolding(s) in Company
9th Feb 20174:53 pmRNSHolding(s) in Company
7th Feb 20175:00 pmRNSDirector Declaration
3rd Feb 20175:23 pmRNSHolding(s) in Company
20th Jan 201710:01 amRNSDirector/PDMR Shareholding
5th Jan 20179:00 amRNSFOMEDEC Contract Award
12th Dec 20161:19 pmRNSDirector Declaration
28th Nov 20164:18 pmRNSHolding(s) in Company
28th Nov 201611:07 amRNSDirector/PDMR Shareholding
23rd Nov 20163:48 pmRNSHolding(s) in Company
23rd Nov 20162:56 pmRNSHolding(s) in Company
22nd Nov 20167:00 amRNSHalf-year Report
21st Nov 201611:13 amRNSContract Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.